nodes	percent_of_prediction	percent_of_DWPC	metapath
Diatrizoate—Anuria—Epirubicin—bone cancer	0.0127	0.0127	CcSEcCtD
Diatrizoate—Anuria—Doxorubicin—bone cancer	0.0118	0.0118	CcSEcCtD
Diatrizoate—Skin necrosis—Doxorubicin—bone cancer	0.0118	0.0118	CcSEcCtD
Diatrizoate—Necrosis—Cisplatin—bone cancer	0.011	0.011	CcSEcCtD
Diatrizoate—Infection—Carboplatin—bone cancer	0.0105	0.0105	CcSEcCtD
Diatrizoate—Nephropathy—Methotrexate—bone cancer	0.00998	0.00998	CcSEcCtD
Diatrizoate—Extravasation—Cisplatin—bone cancer	0.00992	0.00992	CcSEcCtD
Diatrizoate—Pain—Carboplatin—bone cancer	0.009	0.009	CcSEcCtD
Diatrizoate—Azotaemia—Methotrexate—bone cancer	0.00891	0.00891	CcSEcCtD
Diatrizoate—Wheezing—Cisplatin—bone cancer	0.00841	0.00841	CcSEcCtD
Diatrizoate—Body temperature increased—Carboplatin—bone cancer	0.00832	0.00832	CcSEcCtD
Diatrizoate—Skin exfoliation—Cisplatin—bone cancer	0.00826	0.00826	CcSEcCtD
Diatrizoate—Eruption—Methotrexate—bone cancer	0.00772	0.00772	CcSEcCtD
Diatrizoate—Lacrimation—Epirubicin—bone cancer	0.00756	0.00756	CcSEcCtD
Diatrizoate—Eruption—Epirubicin—bone cancer	0.00723	0.00723	CcSEcCtD
Diatrizoate—Lacrimation—Doxorubicin—bone cancer	0.00699	0.00699	CcSEcCtD
Diatrizoate—Paralysis—Methotrexate—bone cancer	0.00684	0.00684	CcSEcCtD
Diatrizoate—Renal failure acute—Cisplatin—bone cancer	0.00681	0.00681	CcSEcCtD
Diatrizoate—Cyanosis—Methotrexate—bone cancer	0.00671	0.00671	CcSEcCtD
Diatrizoate—Amnesia—Cisplatin—bone cancer	0.00669	0.00669	CcSEcCtD
Diatrizoate—Eruption—Doxorubicin—bone cancer	0.00669	0.00669	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Cisplatin—bone cancer	0.00649	0.00649	CcSEcCtD
Diatrizoate—Paralysis—Epirubicin—bone cancer	0.0064	0.0064	CcSEcCtD
Diatrizoate—Thrombosis—Epirubicin—bone cancer	0.00628	0.00628	CcSEcCtD
Diatrizoate—Face oedema—Cisplatin—bone cancer	0.00607	0.00607	CcSEcCtD
Diatrizoate—Necrosis—Methotrexate—bone cancer	0.00605	0.00605	CcSEcCtD
Diatrizoate—Paralysis—Doxorubicin—bone cancer	0.00592	0.00592	CcSEcCtD
Diatrizoate—Blood creatinine increased—Cisplatin—bone cancer	0.00589	0.00589	CcSEcCtD
Diatrizoate—Thrombosis—Doxorubicin—bone cancer	0.00581	0.00581	CcSEcCtD
Diatrizoate—Petechiae—Methotrexate—bone cancer	0.00577	0.00577	CcSEcCtD
Diatrizoate—Feeling hot—Epirubicin—bone cancer	0.00566	0.00566	CcSEcCtD
Diatrizoate—Necrosis—Epirubicin—bone cancer	0.00566	0.00566	CcSEcCtD
Diatrizoate—Cramp muscle—Cisplatin—bone cancer	0.00566	0.00566	CcSEcCtD
Diatrizoate—Speech disorder—Methotrexate—bone cancer	0.00552	0.00552	CcSEcCtD
Diatrizoate—Stinging—Epirubicin—bone cancer	0.00549	0.00549	CcSEcCtD
Diatrizoate—Injection site pain—Epirubicin—bone cancer	0.00544	0.00544	CcSEcCtD
Diatrizoate—Extravasation—Methotrexate—bone cancer	0.00544	0.00544	CcSEcCtD
Diatrizoate—Petechiae—Epirubicin—bone cancer	0.0054	0.0054	CcSEcCtD
Diatrizoate—Feeling hot—Doxorubicin—bone cancer	0.00524	0.00524	CcSEcCtD
Diatrizoate—Necrosis—Doxorubicin—bone cancer	0.00524	0.00524	CcSEcCtD
Diatrizoate—Oliguria—Methotrexate—bone cancer	0.00515	0.00515	CcSEcCtD
Diatrizoate—Extravasation—Epirubicin—bone cancer	0.00509	0.00509	CcSEcCtD
Diatrizoate—Stinging—Doxorubicin—bone cancer	0.00508	0.00508	CcSEcCtD
Diatrizoate—Cardiovascular disorder—Epirubicin—bone cancer	0.00506	0.00506	CcSEcCtD
Diatrizoate—Vasodilation procedure—Epirubicin—bone cancer	0.00506	0.00506	CcSEcCtD
Diatrizoate—Vasodilation—Epirubicin—bone cancer	0.00506	0.00506	CcSEcCtD
Diatrizoate—Injection site pain—Doxorubicin—bone cancer	0.00504	0.00504	CcSEcCtD
Diatrizoate—Petechiae—Doxorubicin—bone cancer	0.005	0.005	CcSEcCtD
Diatrizoate—Cough increased—Epirubicin—bone cancer	0.00486	0.00486	CcSEcCtD
Diatrizoate—Lacrimation increased—Epirubicin—bone cancer	0.00482	0.00482	CcSEcCtD
Diatrizoate—Oliguria—Epirubicin—bone cancer	0.00482	0.00482	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Cisplatin—bone cancer	0.00477	0.00477	CcSEcCtD
Diatrizoate—Renal failure—Cisplatin—bone cancer	0.00476	0.00476	CcSEcCtD
Diatrizoate—Pulmonary embolism—Methotrexate—bone cancer	0.00475	0.00475	CcSEcCtD
Diatrizoate—Myocardial infarction—Cisplatin—bone cancer	0.00475	0.00475	CcSEcCtD
Diatrizoate—Extravasation—Doxorubicin—bone cancer	0.00471	0.00471	CcSEcCtD
Diatrizoate—Conjunctivitis—Cisplatin—bone cancer	0.00471	0.00471	CcSEcCtD
Diatrizoate—Vasodilation procedure—Doxorubicin—bone cancer	0.00468	0.00468	CcSEcCtD
Diatrizoate—Cardiovascular disorder—Doxorubicin—bone cancer	0.00468	0.00468	CcSEcCtD
Diatrizoate—Vasodilation—Doxorubicin—bone cancer	0.00468	0.00468	CcSEcCtD
Diatrizoate—Creatinine increased—Epirubicin—bone cancer	0.00467	0.00467	CcSEcCtD
Diatrizoate—Skin exfoliation—Methotrexate—bone cancer	0.00453	0.00453	CcSEcCtD
Diatrizoate—Cough increased—Doxorubicin—bone cancer	0.00449	0.00449	CcSEcCtD
Diatrizoate—Oliguria—Doxorubicin—bone cancer	0.00446	0.00446	CcSEcCtD
Diatrizoate—Lacrimation increased—Doxorubicin—bone cancer	0.00446	0.00446	CcSEcCtD
Diatrizoate—Pulmonary embolism—Epirubicin—bone cancer	0.00444	0.00444	CcSEcCtD
Diatrizoate—Coma—Methotrexate—bone cancer	0.00434	0.00434	CcSEcCtD
Diatrizoate—Creatinine increased—Doxorubicin—bone cancer	0.00432	0.00432	CcSEcCtD
Diatrizoate—Skin exfoliation—Epirubicin—bone cancer	0.00424	0.00424	CcSEcCtD
Diatrizoate—Pulmonary oedema—Methotrexate—bone cancer	0.00423	0.00423	CcSEcCtD
Diatrizoate—Pulmonary embolism—Doxorubicin—bone cancer	0.00411	0.00411	CcSEcCtD
Diatrizoate—Coma—Epirubicin—bone cancer	0.00406	0.00406	CcSEcCtD
Diatrizoate—Flushing—Cisplatin—bone cancer	0.00403	0.00403	CcSEcCtD
Diatrizoate—Thrombophlebitis—Methotrexate—bone cancer	0.00398	0.00398	CcSEcCtD
Diatrizoate—Pulmonary oedema—Epirubicin—bone cancer	0.00396	0.00396	CcSEcCtD
Diatrizoate—Skin exfoliation—Doxorubicin—bone cancer	0.00393	0.00393	CcSEcCtD
Diatrizoate—Arrhythmia—Cisplatin—bone cancer	0.00388	0.00388	CcSEcCtD
Diatrizoate—Erythema—Cisplatin—bone cancer	0.00378	0.00378	CcSEcCtD
Diatrizoate—Coma—Doxorubicin—bone cancer	0.00376	0.00376	CcSEcCtD
Diatrizoate—Renal failure acute—Methotrexate—bone cancer	0.00373	0.00373	CcSEcCtD
Diatrizoate—Thrombophlebitis—Epirubicin—bone cancer	0.00373	0.00373	CcSEcCtD
Diatrizoate—Pulmonary oedema—Doxorubicin—bone cancer	0.00366	0.00366	CcSEcCtD
Diatrizoate—Muscle spasms—Cisplatin—bone cancer	0.00364	0.00364	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Methotrexate—bone cancer	0.00356	0.00356	CcSEcCtD
Diatrizoate—Tremor—Cisplatin—bone cancer	0.00354	0.00354	CcSEcCtD
Diatrizoate—Anaemia—Cisplatin—bone cancer	0.0035	0.0035	CcSEcCtD
Diatrizoate—Renal failure acute—Epirubicin—bone cancer	0.00349	0.00349	CcSEcCtD
Diatrizoate—Thrombophlebitis—Doxorubicin—bone cancer	0.00345	0.00345	CcSEcCtD
Diatrizoate—Leukopenia—Cisplatin—bone cancer	0.00339	0.00339	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Epirubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Diatrizoate—Convulsion—Cisplatin—bone cancer	0.00328	0.00328	CcSEcCtD
Diatrizoate—Renal failure acute—Doxorubicin—bone cancer	0.00323	0.00323	CcSEcCtD
Diatrizoate—Face oedema—Epirubicin—bone cancer	0.00311	0.00311	CcSEcCtD
Diatrizoate—Anaphylactic shock—Cisplatin—bone cancer	0.00309	0.00309	CcSEcCtD
Diatrizoate—Oedema—Cisplatin—bone cancer	0.00309	0.00309	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Diatrizoate—Cardiac arrest—Epirubicin—bone cancer	0.00307	0.00307	CcSEcCtD
Diatrizoate—Infection—Cisplatin—bone cancer	0.00307	0.00307	CcSEcCtD
Diatrizoate—Thrombocytopenia—Cisplatin—bone cancer	0.00302	0.00302	CcSEcCtD
Diatrizoate—Blood creatinine increased—Epirubicin—bone cancer	0.00302	0.00302	CcSEcCtD
Diatrizoate—Tachycardia—Cisplatin—bone cancer	0.00301	0.00301	CcSEcCtD
Diatrizoate—Hyperhidrosis—Cisplatin—bone cancer	0.00299	0.00299	CcSEcCtD
Diatrizoate—Asthma—Methotrexate—bone cancer	0.00298	0.00298	CcSEcCtD
Diatrizoate—Hypotension—Cisplatin—bone cancer	0.00289	0.00289	CcSEcCtD
Diatrizoate—Face oedema—Doxorubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Diatrizoate—Cardiac arrest—Doxorubicin—bone cancer	0.00284	0.00284	CcSEcCtD
Diatrizoate—Blood creatinine increased—Doxorubicin—bone cancer	0.0028	0.0028	CcSEcCtD
Diatrizoate—Asthma—Epirubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Diatrizoate—Neutropenia—Methotrexate—bone cancer	0.00279	0.00279	CcSEcCtD
Diatrizoate—Paraesthesia—Cisplatin—bone cancer	0.00277	0.00277	CcSEcCtD
Diatrizoate—Dyspnoea—Cisplatin—bone cancer	0.00275	0.00275	CcSEcCtD
Diatrizoate—Pain—Cisplatin—bone cancer	0.00264	0.00264	CcSEcCtD
Diatrizoate—Renal failure—Methotrexate—bone cancer	0.00261	0.00261	CcSEcCtD
Diatrizoate—Neutropenia—Epirubicin—bone cancer	0.00261	0.00261	CcSEcCtD
Diatrizoate—Conjunctivitis—Methotrexate—bone cancer	0.00258	0.00258	CcSEcCtD
Diatrizoate—Asthma—Doxorubicin—bone cancer	0.00258	0.00258	CcSEcCtD
Diatrizoate—Sweating—Methotrexate—bone cancer	0.00255	0.00255	CcSEcCtD
Diatrizoate—Feeling abnormal—Cisplatin—bone cancer	0.00254	0.00254	CcSEcCtD
Diatrizoate—Haematuria—Methotrexate—bone cancer	0.00253	0.00253	CcSEcCtD
Diatrizoate—Renal failure—Epirubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Diatrizoate—Body temperature increased—Cisplatin—bone cancer	0.00244	0.00244	CcSEcCtD
Diatrizoate—Conjunctivitis—Epirubicin—bone cancer	0.00242	0.00242	CcSEcCtD
Diatrizoate—Neutropenia—Doxorubicin—bone cancer	0.00241	0.00241	CcSEcCtD
Diatrizoate—Haemoglobin—Methotrexate—bone cancer	0.0024	0.0024	CcSEcCtD
Diatrizoate—Haemorrhage—Methotrexate—bone cancer	0.00239	0.00239	CcSEcCtD
Diatrizoate—Sweating—Epirubicin—bone cancer	0.00238	0.00238	CcSEcCtD
Diatrizoate—Haematuria—Epirubicin—bone cancer	0.00237	0.00237	CcSEcCtD
Diatrizoate—Renal failure—Doxorubicin—bone cancer	0.00226	0.00226	CcSEcCtD
Diatrizoate—Haemoglobin—Epirubicin—bone cancer	0.00224	0.00224	CcSEcCtD
Diatrizoate—Rhinitis—Epirubicin—bone cancer	0.00224	0.00224	CcSEcCtD
Diatrizoate—Conjunctivitis—Doxorubicin—bone cancer	0.00224	0.00224	CcSEcCtD
Diatrizoate—Haemorrhage—Epirubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Diatrizoate—Hypoaesthesia—Epirubicin—bone cancer	0.00222	0.00222	CcSEcCtD
Diatrizoate—Asthenia—Cisplatin—bone cancer	0.00222	0.00222	CcSEcCtD
Diatrizoate—Sweating—Doxorubicin—bone cancer	0.00221	0.00221	CcSEcCtD
Diatrizoate—Haematuria—Doxorubicin—bone cancer	0.00219	0.00219	CcSEcCtD
Diatrizoate—Chills—Methotrexate—bone cancer	0.00214	0.00214	CcSEcCtD
Diatrizoate—Diarrhoea—Cisplatin—bone cancer	0.00211	0.00211	CcSEcCtD
Diatrizoate—Erythema—Methotrexate—bone cancer	0.00208	0.00208	CcSEcCtD
Diatrizoate—Haemoglobin—Doxorubicin—bone cancer	0.00208	0.00208	CcSEcCtD
Diatrizoate—Flushing—Epirubicin—bone cancer	0.00207	0.00207	CcSEcCtD
Diatrizoate—Rhinitis—Doxorubicin—bone cancer	0.00207	0.00207	CcSEcCtD
Diatrizoate—Haemorrhage—Doxorubicin—bone cancer	0.00207	0.00207	CcSEcCtD
Diatrizoate—Hypoaesthesia—Doxorubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Diatrizoate—Dysgeusia—Methotrexate—bone cancer	0.00203	0.00203	CcSEcCtD
Diatrizoate—Chills—Epirubicin—bone cancer	0.002	0.002	CcSEcCtD
Diatrizoate—Arrhythmia—Epirubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Diatrizoate—Vomiting—Cisplatin—bone cancer	0.00196	0.00196	CcSEcCtD
Diatrizoate—Rash—Cisplatin—bone cancer	0.00195	0.00195	CcSEcCtD
Diatrizoate—Dermatitis—Cisplatin—bone cancer	0.00195	0.00195	CcSEcCtD
Diatrizoate—Erythema—Epirubicin—bone cancer	0.00194	0.00194	CcSEcCtD
Diatrizoate—Anaemia—Methotrexate—bone cancer	0.00192	0.00192	CcSEcCtD
Diatrizoate—Flushing—Doxorubicin—bone cancer	0.00192	0.00192	CcSEcCtD
Diatrizoate—Dysgeusia—Epirubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Diatrizoate—Muscle spasms—Epirubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Diatrizoate—Leukopenia—Methotrexate—bone cancer	0.00186	0.00186	CcSEcCtD
Diatrizoate—Chills—Doxorubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Diatrizoate—Arrhythmia—Doxorubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Diatrizoate—Nausea—Cisplatin—bone cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Cough—Methotrexate—bone cancer	0.00181	0.00181	CcSEcCtD
Diatrizoate—Convulsion—Methotrexate—bone cancer	0.0018	0.0018	CcSEcCtD
Diatrizoate—Erythema—Doxorubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Diatrizoate—Anaemia—Epirubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Diatrizoate—Agitation—Epirubicin—bone cancer	0.00179	0.00179	CcSEcCtD
Diatrizoate—Chest pain—Methotrexate—bone cancer	0.00177	0.00177	CcSEcCtD
Diatrizoate—Dysgeusia—Doxorubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Diatrizoate—Leukopenia—Epirubicin—bone cancer	0.00174	0.00174	CcSEcCtD
Diatrizoate—Muscle spasms—Doxorubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Diatrizoate—Confusional state—Methotrexate—bone cancer	0.00171	0.00171	CcSEcCtD
Diatrizoate—Loss of consciousness—Epirubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Diatrizoate—Cough—Epirubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Diatrizoate—Anaphylactic shock—Methotrexate—bone cancer	0.00169	0.00169	CcSEcCtD
Diatrizoate—Convulsion—Epirubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Diatrizoate—Infection—Methotrexate—bone cancer	0.00168	0.00168	CcSEcCtD
Diatrizoate—Hypertension—Epirubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Diatrizoate—Anaemia—Doxorubicin—bone cancer	0.00166	0.00166	CcSEcCtD
Diatrizoate—Thrombocytopenia—Methotrexate—bone cancer	0.00166	0.00166	CcSEcCtD
Diatrizoate—Chest pain—Epirubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Diatrizoate—Agitation—Doxorubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Diatrizoate—Hyperhidrosis—Methotrexate—bone cancer	0.00164	0.00164	CcSEcCtD
Diatrizoate—Leukopenia—Doxorubicin—bone cancer	0.00161	0.00161	CcSEcCtD
Diatrizoate—Confusional state—Epirubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Diatrizoate—Anaphylactic shock—Epirubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Diatrizoate—Oedema—Epirubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Diatrizoate—Hypotension—Methotrexate—bone cancer	0.00158	0.00158	CcSEcCtD
Diatrizoate—Loss of consciousness—Doxorubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Diatrizoate—Infection—Epirubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Diatrizoate—Cough—Doxorubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Diatrizoate—Shock—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Diatrizoate—Convulsion—Doxorubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Diatrizoate—Thrombocytopenia—Epirubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Diatrizoate—Hypertension—Doxorubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Diatrizoate—Tachycardia—Epirubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Diatrizoate—Hyperhidrosis—Epirubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Diatrizoate—Chest pain—Doxorubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Diatrizoate—Paraesthesia—Methotrexate—bone cancer	0.00152	0.00152	CcSEcCtD
Diatrizoate—Dyspnoea—Methotrexate—bone cancer	0.00151	0.00151	CcSEcCtD
Diatrizoate—Hypotension—Epirubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Diatrizoate—Confusional state—Doxorubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Diatrizoate—Anaphylactic shock—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Diatrizoate—Oedema—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Diatrizoate—Infection—Doxorubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Diatrizoate—Pain—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Diatrizoate—Shock—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Diatrizoate—Thrombocytopenia—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Diatrizoate—Tachycardia—Doxorubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Diatrizoate—Paraesthesia—Epirubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Diatrizoate—Hyperhidrosis—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Diatrizoate—Dyspnoea—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Diatrizoate—Feeling abnormal—Methotrexate—bone cancer	0.0014	0.0014	CcSEcCtD
Diatrizoate—Hypotension—Doxorubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Diatrizoate—Pain—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Diatrizoate—Urticaria—Methotrexate—bone cancer	0.00135	0.00135	CcSEcCtD
Diatrizoate—Body temperature increased—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Diatrizoate—Paraesthesia—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Diatrizoate—Dyspnoea—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Diatrizoate—Feeling abnormal—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Diatrizoate—Urticaria—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Diatrizoate—Pain—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Body temperature increased—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Asthenia—Methotrexate—bone cancer	0.00122	0.00122	CcSEcCtD
Diatrizoate—Feeling abnormal—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Pruritus—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Diatrizoate—Urticaria—Doxorubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Body temperature increased—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Diatrizoate—Diarrhoea—Methotrexate—bone cancer	0.00116	0.00116	CcSEcCtD
Diatrizoate—Asthenia—Epirubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Diatrizoate—Pruritus—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Diatrizoate—Dizziness—Methotrexate—bone cancer	0.00112	0.00112	CcSEcCtD
Diatrizoate—Diarrhoea—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Vomiting—Methotrexate—bone cancer	0.00108	0.00108	CcSEcCtD
Diatrizoate—Rash—Methotrexate—bone cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Dermatitis—Methotrexate—bone cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Headache—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Diatrizoate—Asthenia—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Diatrizoate—Dizziness—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Diatrizoate—Pruritus—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Diatrizoate—Vomiting—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Diatrizoate—Nausea—Methotrexate—bone cancer	0.00101	0.00101	CcSEcCtD
Diatrizoate—Diarrhoea—Doxorubicin—bone cancer	0.001	0.001	CcSEcCtD
Diatrizoate—Rash—Epirubicin—bone cancer	0.001	0.001	CcSEcCtD
Diatrizoate—Dermatitis—Epirubicin—bone cancer	0.000999	0.000999	CcSEcCtD
Diatrizoate—Headache—Epirubicin—bone cancer	0.000993	0.000993	CcSEcCtD
Diatrizoate—Dizziness—Doxorubicin—bone cancer	0.00097	0.00097	CcSEcCtD
Diatrizoate—Nausea—Epirubicin—bone cancer	0.000942	0.000942	CcSEcCtD
Diatrizoate—Vomiting—Doxorubicin—bone cancer	0.000933	0.000933	CcSEcCtD
Diatrizoate—Rash—Doxorubicin—bone cancer	0.000925	0.000925	CcSEcCtD
Diatrizoate—Dermatitis—Doxorubicin—bone cancer	0.000924	0.000924	CcSEcCtD
Diatrizoate—Headache—Doxorubicin—bone cancer	0.000919	0.000919	CcSEcCtD
Diatrizoate—Nausea—Doxorubicin—bone cancer	0.000872	0.000872	CcSEcCtD
